Opioids are frequently used to manage pain and symptoms associated with inflammatory bowel disease. A recent study published in The American Journal of Gastroenterology analyzes the prevalence and risk factors for opioid use in IBD patients.
The researchers found that within 10 years of diagnosis, 5 percent IBD patients became heavy opioid users, defined as continuous use for 30 days at a dose more than 50mg of morphine per day. Moderate use of opioids prior to diagnosis strongly indicated future heavy use. The study also found a strong association between heavy opioid use and mortality.
The study demonstrates IBD is an independent risk factor for becoming a heavy opioid user, and heavy use is strongly linked to mortality in IBD patients .
More articles on gastroenterology:
Dr. Sufiyan Chaudhry joins West Tennessee Gastro
How busy are gastroenterologists?
Defining the ideal GI physician partner
The researchers found that within 10 years of diagnosis, 5 percent IBD patients became heavy opioid users, defined as continuous use for 30 days at a dose more than 50mg of morphine per day. Moderate use of opioids prior to diagnosis strongly indicated future heavy use. The study also found a strong association between heavy opioid use and mortality.
The study demonstrates IBD is an independent risk factor for becoming a heavy opioid user, and heavy use is strongly linked to mortality in IBD patients .
More articles on gastroenterology:
Dr. Sufiyan Chaudhry joins West Tennessee Gastro
How busy are gastroenterologists?
Defining the ideal GI physician partner